Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-mastectomy radiation therapy in Poland syndrome with left breast cancer: A case report.

Experimental and therapeutic medicine·2026
Same author

ASO Author Reflections: Reconsidering Surgical Indications for Clinical T4 Non-Small Cell Lung Cancer in the TNM 9th Edition Era.

Annals of surgical oncology·2026
Same author

Effect of 12-week dynamic stretching of hamstrings on joint flexibility and musculoskeletal properties.

European journal of applied physiology·2026
Same author

Long-term Outcomes of Surgery for Clinical T4 Non-Small Cell Lung Cancer: Implications for Surgical Decision Making in the TNM 9th Edition Era.

Annals of surgical oncology·2026
Same author

Plasma ECRG4 as a novel diagnostic marker for Alzheimer's disease associated with oligodendrocyte dysfunction.

American journal of translational research·2026
Same author

Treatment strategies and outcomes in patients with synchronous multiple primary malignancies involving lung cancer.

International journal of clinical oncology·2026

Related Experiment Video

Updated: May 22, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Pulmonary carcinosarcoma with an osteosarcomatous component.

Ryu Kanzaki1, Naoki Ikeda, Eiji Okura

  • 1Department of General Thoracic Surgery, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, 3-7-1 Habikino, Habikino, Osaka, 583-8588, Japan. rkanzaki@tj8.so-net.ne.jp

General Thoracic and Cardiovascular Surgery
|May 26, 2012
PubMed
Summary

Pulmonary carcinosarcoma, a rare biphasic lung neoplasm, can include an osteosarcoma component. This case highlights a successful curative resection, emphasizing awareness for thoracic surgeons encountering ossified lung tumors.

More Related Videos

Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues
02:35

Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues

Published on: March 22, 2024

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Related Experiment Videos

Last Updated: May 22, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues
02:35

Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues

Published on: March 22, 2024

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Area of Science:

  • Pulmonology
  • Oncology
  • Pathology

Background:

  • Pulmonary carcinosarcoma is a rare lung neoplasm characterized by biphasic components: epithelial and sarcomatous.
  • Squamous cell carcinoma and rhabdomyosarcoma are the most common components, respectively.
  • Carcinosarcomas with osteosarcoma are exceptionally rare.

Observation:

  • This report details a rare case of pulmonary carcinosarcoma with an osteosarcoma component.
  • The patient underwent a potentially curative surgical resection.
  • The presence of ossification within a lung tumor warrants consideration of this rare entity.

Findings:

  • Successful surgical resection achieved a potentially curative outcome for this rare pulmonary carcinosarcoma variant.
  • The case underscores the diagnostic and therapeutic challenges posed by biphasic lung tumors.

Implications:

  • Thoracic surgeons must maintain a high index of suspicion for rare tumors like carcinosarcoma with osteosarcoma.
  • Awareness of ossification as a potential indicator is crucial for timely diagnosis and treatment.
  • Further research into the optimal management of these rare pulmonary neoplasms is warranted.